Clinical Applications and Evidence Landscape of Thymosin Alpha 1 as an Immunomodulatory Adjunct in Cancer Care: A Scoping Review.

Kim SD, Kim KR, Kim DH, Yeo T, Choi MJ, Park SJ, Yoo HS

Open source

DOI
10.3390/ph19091492
Published
2026 Sep 19
Container
Pharmaceuticals (Basel, Switzerland)
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/ph19091492,
  title = {Clinical Applications and Evidence Landscape of Thymosin Alpha 1 as an Immunomodulatory Adjunct in Cancer Care: A Scoping Review.},
  author = {Kim SD and Kim KR and Kim DH and Yeo T and Choi MJ and Park SJ and Yoo HS},
  year = {2026},
  journal = {Pharmaceuticals (Basel, Switzerland)},
  doi = {10.3390/ph19091492},
  url = {https://doi.org/10.3390/ph19091492}
}

RIS

TY  - JOUR
TI  - Clinical Applications and Evidence Landscape of Thymosin Alpha 1 as an Immunomodulatory Adjunct in Cancer Care: A Scoping Review.
AU  - Kim SD
AU  - Kim KR
AU  - Kim DH
AU  - Yeo T
AU  - Choi MJ
AU  - Park SJ
AU  - Yoo HS
PY  - 2026
JO  - Pharmaceuticals (Basel, Switzerland)
DO  - 10.3390/ph19091492
UR  - https://doi.org/10.3390/ph19091492
ER  - 

APA

SD, K., KR, K., DH, K., T, Y., MJ, C., SJ, P., & HS, Y. (2026). Clinical Applications and Evidence Landscape of Thymosin Alpha 1 as an Immunomodulatory Adjunct in Cancer Care: A Scoping Review.. Pharmaceuticals (Basel, Switzerland). https://doi.org/10.3390/ph19091492

Source records